Efficacy and safety of Sleeping Beauty transposon-mediated gene transfer in preclinical animal studies.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Current Gene Therapy

• Publication date

  2011-09-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/156652311797415827PMID 21888621PMCID PMC3728161
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Critical Physiological and Surgical Considerations for Hydrodynamic Pressurization of Individual Segments of the Pig Liver

  2011cited by this paper
• Preexisting immunity and low expression in primates highlight translational challenges for liver-directed AAV8-mediated gene therapy.

  2010cited by this paper
• Naked DNA delivery to whole pig cardiac tissue by coronary sinus retrograde injection employing non‐invasive catheterization

  2010cited by this paper
• Comparative analysis of transposable element vector systems in human cells.

  2010cited by this paper
• Technical requirements for effective regional hydrodynamic gene delivery to the left lateral lobe of the rat liver

  2010cited by this paper
• A transposon and transposase system for human application.

  2010cited by this paper
• Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor.

  2010cited by this paper
• Critical Physiological and Surgical Considerations for Hydrodynamic Gene Delivery to Individual Segments of the Liver in the Rat and Pig Models

  2010cited by this paper
• Progress and prospects: immune responses to viral vectors

  2010cited by this paper
• Harnessing transposons for cancer gene discovery

  2010cited by this paper
• Progress and prospects: nuclear import of nonviral vectors

  2010cited by this paper
• Gene Expression in Lung and Liver After Intravenous Infusion of Polyethylenimine Complexes of Sleeping Beauty Transposons

  2010cited by this paper
• Translating Sleeping Beauty transposition into cellular therapies: Victories and challenges

  2010cited by this paper
• Recognition of virus infection and innate host responses to viral gene therapy vectors.

  2010cited by this paper
• The efficiency of nuclear plasmid DNA delivery is a critical determinant of transgene expression at the single cell level

  2010cited by this paper
• Duration of expression and activity of Sleeping Beauty transposase in mouse liver following hydrodynamic DNA delivery.

  2010cited by this paper
• Effect of Tissue-Specific Promoters and microRNA Recognition Elements on Stability of Transgene Expression After Hydrodynamic Naked Plasmid DNA Delivery

  2009cited by this paper
• Species differences in hepatocyte-directed gene transfer: implications for clinical translation.

  2009cited by this paper
• Long‐term reduction of jaundice in Gunn rats by nonviral liver‐targeted delivery of Sleeping Beauty transposon

  2009cited by this paper
• Image-guided, lobe-specific hydrodynamic gene delivery to swine liver.

  2009cited by this paper
• Current gene therapy.

  2009cited by this paper
• Nanocapsule-delivered Sleeping Beauty mediates therapeutic Factor VIII expression in liver sinusoidal endothelial cells of hemophilia A mice.

  2009cited by this paper
• Cell-intrinsic and vector-related properties cooperate to determine the incidence and consequences of insertional mutagenesis.

  2009cited by this paper
• Hydrodynamic gene delivery to the liver: theoretical and practical issues for clinical application.

  2009cited by this paper
• Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates

  2009cited by this paper
• Systemic correction of storage disease in MPS I NOD/SCID mice using the sleeping beauty transposon system.

  2009influential reference
• Strategies to modulate immune responses: a new frontier for gene therapy.

  2009cited by this paper
• Hydrodynamic gene delivery to the pig liver via an isolated segment of the inferior vena cava

  2008cited by this paper
• Promoters influence the kinetics of transgene expression following adenovector gene delivery

  2008cited by this paper
• Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system.

  2008cited by this paper
• Immune response hinders therapy for lysosomal storage diseases.

  2008cited by this paper
• Computer-assisted hydrodynamic gene delivery.

  2008cited by this paper
• Prolonged susceptibility to antibody-mediated neutralization for adeno-associated vectors targeted to the liver.

  2008cited by this paper
• Cell-specific nuclear import of plasmid DNA in smooth muscle requires tissue-specific transcription factors and DNA sequences

  2008cited by this paper
• Minimally invasive and selective hydrodynamic gene therapy of liver segments in the pig and human

  2008cited by this paper
• Ultrasound mediated delivery of drugs and genes to solid tumors.

  2008cited by this paper
• Sleeping Beauty transposon-mediated engineering of human primary T cells for therapy of CD19+ lymphoid malignancies.

  2008cited by this paper
• Sleeping beauty vector system moves toward human trials in the United States.

  2008cited by this paper
• Insertional mutagenesis and clonal dominance: biological and statistical considerations

  2008cited by this paper
• Structural impact of hydrodynamic injection on mouse liver

  2007cited by this paper
• Promoter Choice for Retroviral Vectors: Transcriptional Strength Versus Trans-Activation Potential

  2007cited by this paper
• Hydrodynamic gene delivery: its principles and applications.

  2007cited by this paper
• AAV Vector Integration Sites in Mouse Hepatocellular Carcinoma

  2007cited by this paper
• Cardiovascular function following acute volume overload for hydrodynamic gene delivery to the liver

  2007cited by this paper
• Pig liver gene therapy by noninvasive interventionist catheterism

  2007cited by this paper
• Messenger RNA as a source of transposase for sleeping beauty transposon-mediated correction of hereditary tyrosinemia type I.

  2007cited by this paper
• Prolonged expression of a lysosomal enzyme in mouse liver after Sleeping Beauty transposon‐mediated gene delivery: implications for non‐viral gene therapy of mucopolysaccharidoses

  2007influential reference
• Preferential delivery of the Sleeping Beauty transposon system to livers of mice by hydrodynamic injection

  2007cited by this paper
• Transient activation of transgene expression by hydrodynamics-based injection may cause rapid decrease in plasmid DNA expression

  2007cited by this paper
• Sustained FVIII expression and phenotypic correction of hemophilia A in neonatal mice using an endothelial-targeted sleeping beauty transposon.

  2006cited by this paper
• Naked plasmid DNA transfer to the porcine liver using rapid injection with large volume

  2006cited by this paper
• Polymers for gene delivery across length scales

  2006cited by this paper
• High volume hydrodynamic injection of plasmid DNA via the hepatic artery results in a high level of gene expression in rat hepatocellular carcinoma induced by diethylnitrosamine

  2006cited by this paper
• Mechanism of plasmid delivery by hydrodynamic tail vein injection. I. Hepatocyte uptake of various molecules

  2006cited by this paper
• Selection of Target Sites for Mobile DNA Integration in the Human Genome

  2006cited by this paper
• Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

  2006influential reference
• Sleeping Beauty‐mediated eNOS gene therapy attenuates monocrotaline‐induced pulmonary hypertension in rats

  2006cited by this paper
• Integration site selection by HIV-based vectors in dividing and growth-arrested IMR-90 lung fibroblasts.

  2006cited by this paper
• Mechanism of plasmid delivery by hydrodynamic tail vein injection. II. Morphological studies

  2006cited by this paper
• RNA as a source of transposase for Sleeping Beauty-mediated gene insertion and expression in somatic cells and tissues.

  2006cited by this paper
• Potential role of pulsed-high intensity focused ultrasound in gene therapy.

  2006cited by this paper
• Hydrodynamic plasmid DNA gene therapy model in liver transplantation.

  2006cited by this paper
• Hydrodynamic liver gene transfer mechanism involves transient sinusoidal blood stasis and massive hepatocyte endocytic vesicles

  2005cited by this paper
• Targeting of polyplexes: toward synthetic virus vector systems.

  2005cited by this paper
• Insertional mutagenesis in mice: new perspectives and tools

  2005cited by this paper
• Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system.

  2005cited by this paper
• Hyperactive transposase mutants of the Sleeping Beauty transposon.

  2005cited by this paper
• Gene transfer for hemophilia: can therapeutic efficacy in large animals be safely translated to patients?

  2005cited by this paper
• The mechanism of naked DNA uptake and expression.

  2005cited by this paper
• Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells.

  2005cited by this paper
• Hepatocyte-targeted gene transfer by combination of vascularly delivered plasmid DNA and in vivo electroporation

  2005cited by this paper
• Genome-wide analysis of retroviral DNA integration

  2005cited by this paper
• Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences

  2004cited by this paper
• Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns.

  2004cited by this paper
• Hydrodynamics‐based procedure involves transient hyperpermeability in the hepatic cellular membrane: implication of a nonspecific process in efficient intracellular gene delivery

  2004cited by this paper
• Long-term transgene expression from plasmid DNA gene therapy vectors is negatively affected by CpG dinucleotides.

  2004cited by this paper
• Mutational Analysis of the N-Terminal DNA-Binding Domain of Sleeping Beauty Transposase: Critical Residues for DNA Binding and Hyperactivity in Mammalian Cells

  2004cited by this paper
• Hydroporation as the mechanism of hydrodynamic delivery

  2004cited by this paper
• Integration and long-term expression in xenografted human glioblastoma cells using a plasmid-based transposon system.

  2004cited by this paper
• Development of hyperactive sleeping beauty transposon vectors by mutational analysis.

  2004cited by this paper
• Sustainable correction of junctional epidermolysis bullosa via transposon-mediated nonviral gene transfer

  2003cited by this paper
• Gene transfer into genomes of human cells by the sleeping beauty transposon system.

  2003cited by this paper
• Hydrodynamic delivery of DNA

  2003cited by this paper
• Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer.

  2003cited by this paper
• Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration

  2003cited by this paper
• Transgene produces massive overexpression of human β-glucuronidase in mice, lysosomal storage of enzyme, and strain-dependent tumors

  2003cited by this paper
• AAV serotype 2 vectors preferentially integrate into active genes in mice

  2003cited by this paper
• Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo.

  2003cited by this paper
• AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.

  2003cited by this paper
• HIV-1 integration in the human genome favors active genes and local hotspots.

  2002cited by this paper
• In vivo correction of murine tyrosinemia type I by DNA-mediated transposition.

  2002cited by this paper
• Development of Catheter-Based Procedures for Transducing the Isolated Rabbit Liver with Plasmid DNA

  2002cited by this paper
• Structure-function analysis of the inverted terminal repeats of the sleeping beauty transposon.

  2002cited by this paper
• The gene expression fingerprint of human heart failure

  2002cited by this paper
• Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy.

  2002cited by this paper
• High‐level expression of naked DNA delivered to rat liver via tail vein injection

  2002cited by this paper
• Cellular Gene Dose and Kinetics of Gene Expression in Mouse Livers Transfected by High-Volume Tail-Vein Injection of Naked DNA

  2002cited by this paper
• Surface-tethered DNA complexes for enhanced gene delivery.

  2002cited by this paper
• Gene silencing as a threat to the success of gene therapy.

  2000cited by this paper
• Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system

  2000cited by this paper

• Mage transposon: a novel gene delivery system for mammalian cells

  2024cites this paper
• Early Subcellular Hepatocellular Alterations in Mice Post Hydrodynamic Transfection: An Explorative Study

  2023cites this paper
• The Past, Present, and Future of Non-Viral CAR T Cells

  2022cites this paper
• CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma

  2021cites this paper
• Novel vectors and approaches for gene therapy in liver diseases

  2021cites this paper
• The potential of gene therapy for mucopolysaccharidosis type I

  2020cites this paper
• The Role of Checkpoint Inhibitors and Cytokines in Adoptive Cell-Based Cancer Immunotherapy with Genetically Modified T Cells

  2019cites this paper
• Translational Advances of Hydrofection by Hydrodynamic Injection

  2018cites this paper
• Liver-Specific Delivery of Sleeping Beauty Transposon System by Hydrodynamic Injection for Cancer Gene Validation.

  2018cites this paper
• Liver Gene Therapy: Employing Surgery and Radiology for Translational Research

  2018cites this paper
• Retrofitting baculoviral vector with Sleeping Beauty transposon system: competent for long-term reporter gene imaging in vivo

  2018cites this paper
• Toward Engineered Cells as Transformational and Broadly Available Medicines for the Treatment of Cancer

  2018cites this paper
• The development of a novel S/MAR DNA vector platform for the stable, persistent and safe genetic engineering of dividing cells

  2018cites this paper
• Wide Awake and Ready to Move: 20 Years of Non-Viral Therapeutic Genome Engineering with the Sleeping Beauty Transposon System

  2017cites this paper
• Gene Therapy with the Sleeping Beauty Transposon System.

  2017cites this paper
• Transgene Expression in Dogs After Liver-Directed Hydrodynamic Delivery of Sleeping Beauty Transposons Using Balloon Catheters

  2017cites this paper
• Going non-viral: the Sleeping Beauty transposon system breaks on through to the clinical side

  2017cites this paper
• Trehalose-Based Block Copolycations Promote Polyplex Stabilization for Lyophilization and in Vivo pDNA Delivery.

  2017cites this paper
• Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer

  2017cites this paper
• A Novel Ideal Radionuclide Imaging System for Non-invasively Cell Monitoring built on Baculovirus Backbone by Introducing Sleeping Beauty Transposon

  2017cites this paper
• Preclinical and clinical advances in transposon-based gene therapy

  2017cites this paper
• Transposons: Moving Forward from Preclinical Studies to Clinical Trials

  2017cites this paper
• Adenovirus-mediated gene delivery: Potential applications for gene and cell-based therapies in the new era of personalized medicine

  2017cites this paper
• Prolonged Expression of Secreted Enzymes in Dogs After Liver-Directed Delivery of Sleeping Beauty Transposons: Implications for Non-Viral Gene Therapy of Systemic Disease

  2017cites this paper
• Molécules de récepteur d'antigène chimérique et leurs utilisations

  2016cites this paper
• Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System.

  2016cites this paper
• Adoptive Cellular Therapy With Synthetic T Cells as an “Instant Vaccine” for Cancer and Immunity

  2016cites this paper
• Genome-wide Profiling Reveals Remarkable Parallels Between Insertion Site Selection Properties of the MLV Retrovirus and the piggyBac Transposon in Primary Human CD4+ T Cells

  2016cites this paper
• Cell based therapeutics for retinal degenerations

  2016cites this paper
• Neuroprotective therapies in glaucoma: II. Genetic nanotechnology tools

  2015cites this paper
• Trehalose-Based Block Copolycations Promote Polyplex Stabilization for Lyophilization and in Vivo pDNA Delivery

  2015cites this paper
• Lysosomal storage disease: gene therapy on both sides of the blood-brain barrier.

  2015cites this paper
• Manufacture of T cells using the Sleeping Beauty system to enforce expression of a CD19-specific chimeric antigen receptor

  2015cites this paper
• Gene therapy for hemophilia.

  2015cites this paper
• Risks of Insertional Mutagenesis by DNA Transposons in Cancer Gene Therapy

  2015cites this paper
• Nonviral Gene Therapy—The Challenge of Mobilizing DNA

  2015cites this paper
• REDIRECTING T CELLS WITH CHIMERIC ANTIGEN RECEPTORS TO TARGET CD123+ LEUKEMIA

  2015cites this paper
• The sleeping beauty transposon vector system for treatment of rare genetic diseases: an unrealized hope?

  2015cites this paper
• A new approach to gene therapy using Sleeping Beauty to genetically modify clinical‐grade T cells to target CD19

  2014cites this paper
• Ex Vivo Gene Therapy

  2014cites this paper
• Hemodynamics of a hydrodynamic injection

  2014cites this paper
• State-of-the-art human gene therapy: part I. Gene delivery technologies.

  2014cites this paper
• DNA Plasmids for Non-viral Gene Therapy of Cancer

  2014cites this paper
• Rational design for enhanced gene therapy with DNA transposons.

  2014cites this paper
• Engineered T cells for cancer treatment.

  2014cites this paper
• Induced pluripotent stem cells: From derivation to application in biochemical and biomedical research

  2014cites this paper
• Delivery of Full-Length Factor VIII Using a piggyBac Transposon Vector to Correct a Mouse Model of Hemophilia A

  2014cites this paper
• piggyBac-mediated phenotypic correction of factor VIII deficiency

  2014cites this paper
• Clinical Applications of Gamma Delta T Cells with Multivalent Immunity

  2014cites this paper
• T-CELL TREATMENTS FOR SOLID AND HEMATOLOGICAL TUMORS

  2013cites this paper
• Quantitative Analysis of α-L-Iduronidase Expression in Immunocompetent Mice Treated with the Sleeping Beauty Transposon System

  2013cites this paper
• Vectors for gene therapy: A place for DNA transposon

  2013cites this paper
• Animal Models of human Cancer

  2013cites this paper
• Adoptive T-cell Therapy

  2013cites this paper
• Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

  2013cites this paper
• Ex vivo gene therapy and vision.

  2012cites this paper
• Assessment of Fecundity and Germ Line Transmission in Two Transgenic Pig Lines Produced by Sleeping Beauty Transposition

  2012cites this paper
• Advancements in Non Viral Gene Therapy for Hemophilia

  2012cites this paper
• The Sleeping Beauty transposon system: a non-viral vector for gene therapy.

  2011cites this paper